JP2008255078A - Humectant, anti-aging agent, skin beautifying agent, antioxidant, slimming agent, treatment agent, arginase activity accelerator and skin external preparation - Google Patents

Humectant, anti-aging agent, skin beautifying agent, antioxidant, slimming agent, treatment agent, arginase activity accelerator and skin external preparation Download PDF

Info

Publication number
JP2008255078A
JP2008255078A JP2007101941A JP2007101941A JP2008255078A JP 2008255078 A JP2008255078 A JP 2008255078A JP 2007101941 A JP2007101941 A JP 2007101941A JP 2007101941 A JP2007101941 A JP 2007101941A JP 2008255078 A JP2008255078 A JP 2008255078A
Authority
JP
Japan
Prior art keywords
extract
agent
skin
plants
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007101941A
Other languages
Japanese (ja)
Other versions
JP5117092B2 (en
Inventor
Hiroko Kikuchi
宏子 菊池
Ryuji Nakauchi
龍二 中内
Hiroko Yoshida
浩子 吉田
Kentaro Yagi
健太郎 八木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noevir Co Ltd
Original Assignee
Noevir Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noevir Co Ltd filed Critical Noevir Co Ltd
Priority to JP2007101941A priority Critical patent/JP5117092B2/en
Priority to PCT/JP2007/073499 priority patent/WO2008129720A1/en
Publication of JP2008255078A publication Critical patent/JP2008255078A/en
Application granted granted Critical
Publication of JP5117092B2 publication Critical patent/JP5117092B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/27Asclepiadaceae (Milkweed family), e.g. hoya
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/06Preparations for care of the skin for countering cellulitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers

Abstract

<P>PROBLEM TO BE SOLVED: To provide humectants, anti-aging agents, skin beautifying agents, antioxidants, slimming agents, treatment agents, and arginase activity accelerators, which are widely applicable to the fields such of skin external agents. <P>SOLUTION: The humectants, anti-aging agents, skin beautifying agents, antioxidants, slimming agents, treatment agents, arginase activity accelerators, and skin external agents each comprise, as an effective ingredient, an extract of a plant belonging to genus Cynanchum, Asclepiadaceae family, for example, Cynanchum atratum, Cynanchum caudatum, Cynanchum versico, Cynanchum paniculatum, or Cynanchum wilfordii. <P>COPYRIGHT: (C)2009,JPO&INPIT

Description

本発明は、天然由来成分を有効成分とする保湿剤、抗老化剤、美白剤、抗酸化剤、痩身剤、トリートメント剤、アルギナーゼ活性促進剤及び皮膚外用剤に関する。さらに詳しくは、ガガイモ科(Asclepiadaceae)カモメヅル属(Cynanchum)植物またはその抽出物を含有する保湿剤、抗老化剤、美白剤、抗酸化剤、痩身剤、トリートメント剤、アルギナーゼ活性促進剤及び皮膚外用剤に関する。 The present invention relates to a moisturizing agent, an anti-aging agent, a whitening agent, an antioxidant, a slimming agent, a treatment agent, an arginase activity promoter and an external preparation for skin, which comprise a naturally derived ingredient as an active ingredient. More specifically, a moisturizer, an anti-aging agent, a whitening agent, an antioxidant, a slimming agent, a treatment agent, an arginase activity promoter and an external preparation for skin containing the plant of the genus Asclepiadaceae or Cynanchuum. About.

加齢、疾患、ストレス、紫外線などによるシワ、シミ、皮膚の弾力低下といった皮膚症状の要因として、乾燥、細胞機能機能低下、紫外線によるメラニン産生や色素沈着、真皮マトリックス成分の減少や変性、紫外線等による細胞の酸化障害などが挙げられる。このような皮膚症状を防止・改善するために、様々な有効成分の検索及び配合検討がなされてきた。特に天然由来成分は、様々な薬理作用や美容効果を有することが知られ、これまでにも数多くの植物や菌類などの抽出物の皮膚外用剤への応用が検討されてきた。   Causes of skin symptoms such as aging, disease, stress, UV wrinkles, stains, reduced skin elasticity, dryness, decreased cellular function, melanin production and pigmentation due to UV rays, decrease and degeneration of dermal matrix components, UV rays, etc. Oxidative damage of cells due to. In order to prevent and ameliorate such skin symptoms, various active ingredients have been searched and formulated. In particular, naturally-derived components are known to have various pharmacological and cosmetic effects, and so far, applications of extracts such as plants and fungi to skin external preparations have been studied.

例えば、保湿効果と安全性に優れた保湿剤としてキク科ハマグルマ属植物の抽出物(特許文献1参照)、アブラナ科レピディウム属植物の抽出物(特許文献2参照)が知られている。皮膚の老化防止、改善作用を有する皮膚外用剤を得るために、真皮線維芽細胞の賦活あるいは増殖促進作用を有する成分としてポンカンのエッセンス(特許文献3参照)、ツリガネニンジン属植物の抽出物(特許文献4参照)、クロレラ抽出物(特許文献5参照)、ビワ抽出物(特許文献6参照)が開示されている。美白剤としては、白鶴霊芝の抽出物(特許文献7参照)、抗酸化剤としてはサルオガセ科サルオガセ属植物の抽出物(特許文献8参照)、生体内の脂肪蓄積を抑制する成分として哺乳動物の乳由来リン脂質(特許文献9参照)、褐藻の酵素分解物(特許文献10参照)、アルギナーゼ活性促進剤として木通抽出物(特許文献11参照)、桔梗抽出物(特許文献12参照)、麦門冬抽出物(特許文献13参照)、アンズ果実(特許文献14参照)が知られている。   For example, as a moisturizing agent having excellent moisturizing effect and safety, an extract of the genus Asteraceae (see Patent Literature 1) and an extract of the Brassicaceae Repidium plant (see Patent Literature 2) are known. In order to obtain an external preparation for skin having anti-aging and improving effects on skin, essence of Ponkan (see Patent Document 3) as an ingredient having an activity of promoting dermal fibroblasts or promoting proliferation (see Patent Document 3) (Patent Document) 4), chlorella extract (see Patent Document 5), and loquat extract (see Patent Document 6). As a whitening agent, an extract of white crane ganoderma (see Patent Document 7), as an antioxidant, an extract of a plant belonging to the genus Salogaceae (see Patent Document 8), a mammal as a component that suppresses fat accumulation in the living body. Milk-derived phospholipids (see Patent Document 9), brown algal enzyme degradation product (see Patent Document 10), Arginase activity promoter as a tree extract (see Patent Document 11), bellflower extract (see Patent Document 12), Mumon winter extract (see Patent Document 13) and apricot fruit (see Patent Document 14) are known.

特開2002−20262号公報JP 2002-20262 A 特開2005−281271号公報JP 2005-281271 A 特開2001−131045号公報JP 2001-131045 A 特開2000−178198号公報JP 2000-178198 A 特開平11−335293号公報JP 11-335293 A 特公平5−17206号公報Japanese Patent Publication No. 5-17206 特開2003−89630号公報JP 2003-89630 A 特開平10−182413号公報Japanese Patent Laid-Open No. 10-182413 特開2001−275614号公報JP 2001-275614 A 特開平7−278005号公報JP-A-7-278005 特開平10−7581号公報Japanese Patent Laid-Open No. 10-7581 特開2002−29983号公報JP 2002-29983 A 特開2003−277285号公報JP 2003-277285 A 特開2006−143608号公報JP 2006-143608 A

このように、これまでに様々な天然由来成分が応用されている。しかし、天然由来成分の中には、未だその効果が知られていないものも数多く存在し、優れた保湿作用、抗老化作用、美白作用、抗酸化作用、痩身作用、トリートメント作用、アルギナーゼ活性促進作用などを有する有効成分の開発が期待されていた。   Thus, various naturally-derived components have been applied so far. However, there are many naturally-derived ingredients whose effects are not yet known. Excellent moisturizing action, anti-aging action, whitening action, antioxidant action, slimming action, treatment action, arginase activity promoting action Development of an active ingredient having such as was expected.

本発明者らは、天然由来の種々の成分について検討を行った結果、従来はその効果が知られていなかったガガイモ科(Asclepiadaceae)カモメヅル属(Cynanchum)植物またはその抽出物に優れた保湿作用、抗老化作用、美白作用、抗酸化作用、痩身作用、トリートメント作用、アルギナーゼ活性促進作用が存在することを見出し、さらに検討を重ねて本発明を完成させるに至った。 The present inventors have made examined various components of natural origin, conventionally the effect was not known Asclepiadaceae (Asclepiadaceae) vincetoxicum (Cynanchum) moisturizing effect having excellent plant or an extract thereof, The present inventors have found that an anti-aging action, a whitening action, an antioxidant action, a slimming action, a treatment action, and an arginase activity promoting action exist, and have further studied and completed the present invention.

すなわち、本発明は、ガガイモ科(Asclepiadaceae)カモメヅル属(Cynanchum)植物より選ばれる1種または2種以上の植物またはその抽出物を有効成分とする保湿剤、抗老化剤、美白剤、抗酸化剤、痩身剤、トリートメント剤またはアルギナーゼ活性促進剤に関する。 That is, the present invention is a humectant to Asclepiadaceae (Asclepiadaceae) vincetoxicum (Cynanchum) 1 or more kinds of plants or active ingredient the extract is selected from plant, anti-aging agents, whitening agents, anti-oxidants , Slimming agents, treatment agents or arginase activity promoters.

別の発明はガガイモ科(Asclepiadaceae)カモメヅル属(Cynanchum)植物より選ばれる1種または2種以上の植物またはその抽出物を含有することを特徴とする皮膚外用剤に関する。 Another invention relates to a skin external preparation characterized by containing one or more plants selected from Asclepiadaceae plants and cynanchuum plants or extracts thereof.

本発明によれば、ガガイモ科(Asclepiadaceae)カモメヅル属(Cynanchum)植物より選ばれる1種または2種以上の植物またはその抽出物を有効成分とすることにより、優れた効果を有する保湿剤、抗老化剤、美白剤、抗酸化剤、痩身剤、トリートメント剤およびアルギナーゼ活性促進剤を提供することができる。 According to the present invention, a moisturizer and an anti-aging agent having an excellent effect by using as an active ingredient one or two or more kinds of plants selected from the genus Asclepiadaceae, Cynanchum, or an extract thereof. Agents, whitening agents, antioxidants, slimming agents, treatment agents and arginase activity promoters can be provided.

これらの保湿剤、抗老化剤、美白剤、抗酸化剤、痩身剤、トリートメント剤、アルギナーゼ活性促進剤を化粧料、外用医薬品等の皮膚外用剤に配合することにより、シワ、タルミ、皮膚の弾力低下、シミ、くすみいった種々の皮膚症状の発現防止や改善に優れた効果を発揮する、様々な組成物を提供することができる。   By adding these moisturizers, anti-aging agents, whitening agents, antioxidants, slimming agents, treatment agents, and arginase activity promoters to skin external preparations such as cosmetics and topical medicines, wrinkles, tarmi and skin elasticity It is possible to provide various compositions that exhibit an excellent effect in preventing and improving various skin symptoms such as reduction, spots, and dullness.

ガガイモ科(Asclepiadaceae)カモメヅル属(Cynanchum)植物としては、フナバラソウ(Cynanchum atratum Bunge;Vincetoxicum hirundiaria)、イケマ(Cynanchum caudatum (Miq.)Maxim.)、ビャクビ(Cynanchum versico Bunge)、スズサイコ(Cynanchum paniculatum (Bunge)Kitagawa)、コイケマ(Cynanchum wilfordii(Maxim.)Hemsl.)が知られている。 Asclepiadaceae (Asclepiadaceae) vincetoxicum The (Cynanchum) plants, Funabarasou (Cynanchum atratum Bunge; Vincetoxicum hirundiaria) , Ikema (.. Cynanchum caudatum (Miq) Maxim), Byakubi (Cynanchum versico Bunge), Suzusaiko (Cynanchum paniculatum (Bunge) Kitagawa), Koikema (Cynanchum wilfordii (Maxim.) Hemsl .) is known.

これらの植物は、単独で用いられるほか、2種以上を組み合わせて使用することもできる。   These plants can be used alone or in combination of two or more.

本発明は、ガガイモ科カモメヅル属植物であれば特に限定されないが、入手が比較的容易などの理由から、適当なものとして、イケマ(Cynanchum caudatum (Miq.)Maxim.)が挙げられる。 The present invention is not particularly limited as long as it is a member of the genus Camellia belonging to the genus Turtle, but for reasons such as being relatively easy to obtain, a suitable example is Ikenma ( Cynanchum caudatum (Miq.) Maxim.).

これらガガイモ科カモメヅル属植物を使用する際は、その使用部位には特に制限はなく、根、茎、幹、葉、花などの任意の部分を使用することができる。複数の部位を組み合わせて使用してもよい。   There are no particular restrictions on the site of use when using these genus Camellia plants, and any part such as roots, stems, trunks, leaves, and flowers can be used. A plurality of parts may be used in combination.

それらはそのまま粉砕して使用することもできるが、それらの部位からの抽出物を用いることが好ましい。   They can be pulverized as they are, but it is preferable to use an extract from those parts.

抽出には、ガガイモ科カモメヅル属植物のいずれの部位を用いても構わないが、簡便に利用するには、全草、根、葉、花などを用いるとよい。その際、複数の部位を用いて抽出物を得るようにしてもよい。また、異なる溶媒を用いて抽出された抽出物を2種以上混合して用いてもよい。   For extraction, any part of the genus Camellia species may be used, but whole plants, roots, leaves, flowers, etc. may be used for convenient use. In that case, you may make it obtain an extract using a some site | part. Further, two or more kinds of extracts extracted using different solvents may be mixed and used.

抽出の際は、植物を生のまま用いてもよいが、抽出効率を考えると、細切、乾燥、粉砕等の処理を行った後に抽出を行うことが好ましい。   In the extraction, the plant may be used as it is, but considering the extraction efficiency, it is preferable to perform the extraction after performing processing such as shredding, drying, and pulverization.

抽出は、任意の抽出溶媒に所定時間浸漬して行うことができる。抽出溶媒は、必要に応じて加熱してもよい。あるいは、超臨界流体や亜臨界流体を用いた抽出方法でも行うことができる。抽出効率を上げるため、撹拌したり抽出溶媒中でホモジナイズしたりしてもよい。抽出温度としては、5℃程度から抽出溶媒の沸点以下の温度とするのが適切である。抽出時間は、抽出溶媒の種類や抽出温度によっても異なるが、1時間〜14日間程度とするのが適切である。   The extraction can be performed by immersing in an arbitrary extraction solvent for a predetermined time. The extraction solvent may be heated as necessary. Alternatively, extraction can be performed using a supercritical fluid or a subcritical fluid. In order to increase the extraction efficiency, stirring or homogenization in an extraction solvent may be performed. The extraction temperature is suitably about 5 ° C. to the boiling point of the extraction solvent. The extraction time varies depending on the type of extraction solvent and the extraction temperature, but is suitably about 1 hour to 14 days.

抽出溶媒としては、水の他、メタノール、エタノール、プロパノール、イソプロパノール等の低級アルコール;1,3−ブチレングリコール、プロピレングリコール、ジプロピレングリコール、グリセリン等の多価アルコール;エチルエーテル、プロピルエーテル等のエーテル類;酢酸ブチル、酢酸エチル等のエステル類;アセトン、エチルメチルケトン等のケトン類などの溶媒を用いることができる。これらは、単独で用いられるほか、任意の2種以上を組み合わせて用いてもよい。生理食塩水、リン酸緩衝液、リン酸緩衝生理食塩水等を用いてもよい。さらに、水や二酸化炭素、エチレン、プロピレン、エタノール、メタノール、アンモニアなどの1種又は2種以上の超臨界液体や亜臨界液体を用いてもよい。   As an extraction solvent, in addition to water, lower alcohols such as methanol, ethanol, propanol and isopropanol; polyhydric alcohols such as 1,3-butylene glycol, propylene glycol, dipropylene glycol and glycerin; ethers such as ethyl ether and propyl ether Solvents such as esters; esters such as butyl acetate and ethyl acetate; ketones such as acetone and ethyl methyl ketone can be used. These may be used alone or in combination of any two or more. Saline, phosphate buffer, phosphate buffered saline, and the like may be used. Furthermore, you may use 1 type, or 2 or more types of supercritical liquids and subcritical liquids, such as water, a carbon dioxide, ethylene, propylene, ethanol, methanol, ammonia.

ガガイモ科カモメヅル属植物の上記溶媒による抽出物は、そのままでも使用することができるが、一定期間そのまま放置して熟成させて用いてもよいし、濃縮、乾固した物を水や極性溶媒に再度溶解して使用することもできる。或いは、これらの生理作用を損なわない範囲で、脱色、脱臭、脱塩等の精製処理や、カラムクロマトグラフィー等による分画処理を行った後に用いてもよい。ガガイモ科カモメヅル属植物の前記抽出物やその処理物及び分画物は、各処理及び分画後に凍結乾燥し、用時に溶媒に溶解して用いることもできる。また、リポソーム等のベシクルやマイクロカプセル等に内包させて用いることもできる。   The above-mentioned extract of the genus Camellia belonging to the genus Camellia can be used as it is, but it can be left to mature for a certain period of time, or the concentrated and dried product can be used again in water or a polar solvent. It can also be used by dissolving. Alternatively, it may be used after performing purification treatment such as decolorization, deodorization, desalting, etc., or fractionation treatment by column chromatography or the like, as long as these physiological functions are not impaired. The above-mentioned extract of the genus Camellia spp., The processed product and the fraction thereof can be freeze-dried after each treatment and fractionation, and dissolved in a solvent at the time of use. It can also be used by encapsulating in vesicles such as liposomes or microcapsules.

ガガイモ科カモメヅル属植物またはその抽出物は、優れた保湿作用、抗老化作用、美白作用、抗酸化作用、痩身作用、トリートメント作用、アルギナーゼ活性促進作用を有し、保湿剤、抗老化剤、美白剤、抗酸化剤、痩身剤、トリートメント剤、アルギナーゼ活性促進剤として利用することができる。   The genus Camellia spp. Or its extract has excellent moisturizing, anti-aging, whitening, antioxidant, slimming, treatment, arginase activity promoting, moisturizing, anti-aging, whitening. It can be used as an antioxidant, slimming agent, treatment agent, and arginase activity promoter.

これらの各剤は、ガガイモ科カモメヅル属植物またはその抽出物を有効成分として含む限り、その形態およびその他成分の配合の有無等については、何ら制限されない。形態については、液状、ペースト状、ゲル状、固体状、粉末状等の任意の形態を、その用途等に応じて選択でき、その形態とするために必要なビヒクル(賦形剤)、溶剤、その他の一般的な添加剤(酸化防止剤、着色剤、分散剤等)を任意に含むことができる。   Each of these agents is not limited at all in terms of its form and presence / absence of other components as long as it contains the genus Camellia plant or its extract as an active ingredient. As for the form, any form such as liquid, paste, gel, solid, powder, etc. can be selected according to its use and the like, vehicle (excipient), solvent, Other general additives (antioxidants, colorants, dispersants, etc.) can optionally be included.

ガガイモ科カモメヅル属植物またはその抽出物を有効成分とする保湿剤は、皮膚や毛髪等に優れた保湿効果を与えることができる。   A moisturizing agent containing an active ingredient of the genus Camellia spp. Or an extract thereof can give an excellent moisturizing effect to the skin and hair.

ガガイモ科カモメヅル属植物またはその抽出物を有効成分とする抗老化剤は、優れたヒト真皮線維芽細胞の細胞賦活効果、コラーゲン産生促進作用を有し、老化症状の防止・改善に優れた効果を発揮する。   An anti-aging agent comprising an active ingredient of the genus Camellia spp. Or its extract has an excellent cell activating effect on human dermal fibroblasts and an effect of promoting collagen production, and has an excellent effect on the prevention and improvement of aging symptoms. Demonstrate.

ガガイモ科カモメヅル属植物またはその抽出物を有効成分とする美白剤は、優れたヒト表皮メラニン細胞のチロシナーゼ活性阻害効果を有し、色素沈着、シミ、そばかす等を予防および改善して、優れた美白作用を発揮する。   A whitening agent comprising a genus Gagamella plant or an extract thereof as an active ingredient has an excellent inhibitory effect on tyrosinase activity of human epidermal melanocytes, and prevents and improves pigmentation, blemishes, freckles, etc. Demonstrate the effect.

ガガイモ科カモメヅル属植物またはその抽出物を有効成分とする抗酸化剤は、優れたラジカル消去効果およびスーパーオキサイドアニオン消去効果を有し、優れた抗酸化作用を発揮する。   Antioxidants containing the genus Camellia plant or its extract as an active ingredient have an excellent radical scavenging effect and a superoxide anion scavenging effect, and exhibit an excellent antioxidant action.

ガガイモ科カモメヅル属植物またはその抽出物を有効成分とする痩身剤は、優れたヒト前駆脂肪細胞の中性脂肪蓄積抑制効果を有し、優れた痩身作用を発揮する。   A slimming agent comprising a genus Camellia plant or an extract thereof as an active ingredient has an excellent effect of suppressing neutral fat accumulation in human preadipocytes and exhibits an excellent slimming action.

ガガイモ科カモメヅル属植物またはその抽出物を有効成分とするトリートメント剤は、肌荒れ、小じわ、くすみといった皮膚症状の改善に優れた効果を発揮し、肌のキメを整え、肌の透明感を高めることができる。   A treatment agent containing the genus Camellia genus plant or its extract as an active ingredient is effective in improving skin symptoms such as rough skin, fine lines and dullness, and can improve skin texture and enhance skin transparency. it can.

ガガイモ科カモメヅル属植物またはその抽出物を有効成分とするアルギナーゼ活性促進剤は、優れたヒト表皮角化細胞のアルギナーゼ活性促進効果を有し、優れたアルギナーゼ活性促進作用を発揮する。   An arginase activity promoter comprising a genus Camellia plant or an extract thereof as an active ingredient has an excellent arginase activity promoting effect on human keratinocytes, and exhibits an excellent arginase activity promoting action.

ガガイモ科カモメヅル属植物またはその抽出物を、化粧品、外用医薬品、医薬部外品等の皮膚外用剤に配合することにより、シワ、タルミ、シミ、くすみ、乾燥、小じわ等の様々な皮膚症状の防止・改善に優れた効果を発揮する皮膚外用剤を得ることができる。したがって、たとえば、保湿用皮膚外用剤、老化防止用皮膚外用剤、痩身用皮膚外用剤または美白用皮膚外用剤として好ましく使用することができる。   Prevention of various skin symptoms such as wrinkles, tarmi, blemishes, dullness, dryness and fine wrinkles by blending the genus Camellia genus plant or its extract with topical skin preparations such as cosmetics, topical medicines and quasi drugs -It is possible to obtain an external preparation for skin that exhibits an excellent effect of improvement. Therefore, for example, it can be preferably used as a skin external preparation for moisturizing, a skin external preparation for preventing aging, a skin external preparation for slimming, or a skin external preparation for whitening.

ガガイモ科カモメヅル属植物またはその抽出物の皮膚外用剤中の配合量は、皮膚外用剤の種類や目的等によって調整することができるが、効果や安定性などの点から、皮膚外用剤全量に対して、固形分換算で、0.0001〜10.0質量%が好ましく、より好ましくは、0.001〜5.0質量%であり、さらに好ましくは0.01〜5質量%であり、一層好ましくは0.1〜5質量%である。   The amount of the genus Camellia spp. Or its extract in the external preparation for skin can be adjusted according to the type and purpose of the external preparation for skin, but from the standpoint of efficacy and stability, the total amount of external preparation for skin In terms of solid content, 0.0001 to 10.0 mass% is preferable, more preferably 0.001 to 5.0 mass%, still more preferably 0.01 to 5 mass%, and still more preferably. Is 0.1-5 mass%.

皮膚外用剤の剤型は任意であり、例えば、ローション、乳液、ゲル、クリーム、軟膏剤、粉末、顆粒、パック剤、貼布剤、パップ剤、エアゾール剤等、種々の剤型で提供することができる。   The dosage form of the external preparation for skin is arbitrary. For example, it should be provided in various dosage forms such as lotion, emulsion, gel, cream, ointment, powder, granule, pack, patch, patch, aerosol, etc. Can do.

皮膚外用剤には、ガガイモ科カモメヅル属植物またはその抽出物の他に、その用途と必要に応じて、医薬品、医薬部外品、皮膚化粧料、毛髪用化粧料及び洗浄料等に通常配合される任意の成分、例えば水、油性成分、保湿剤、粉体、色素、乳化剤、可溶化剤、ゲル化剤、洗浄剤、紫外線吸収剤、抗炎症剤、増粘剤、pH調整剤、キレート剤、薬剤(薬効成分)、香料、樹脂、防腐剤、アルコール類等を適宜配合することができる。さらに、本発明の効果を損なわない範囲において、他の保湿剤、抗老化剤、美白剤、抗酸化剤、痩身剤、トリートメント剤、アルギナーゼ活性促進剤あるいはガガイモ科カモメヅル属植物以外の植物またはその抽出物との併用も可能である。   In addition to the genus Camellia gull plant or its extract, the topical skin preparation is usually formulated into pharmaceuticals, quasi-drugs, skin cosmetics, hair cosmetics, and cleansing agents, etc. as necessary and necessary. Optional ingredients such as water, oily ingredients, moisturizers, powders, pigments, emulsifiers, solubilizers, gelling agents, detergents, UV absorbers, anti-inflammatory agents, thickeners, pH adjusters, chelating agents Drugs (medicinal ingredients), fragrances, resins, preservatives, alcohols and the like can be appropriately blended. In addition, other moisturizers, anti-aging agents, whitening agents, antioxidants, slimming agents, treatment agents, arginase activity promoters or plants other than the genus Camellia sp. It can also be used in combination with goods.

以下にガガイモ科(Asclepiadaceae)カモメヅル属(Cynanchum)植物抽出物の調製例、各作用を評価するための試験、皮膚外用剤としての処方例、使用試験についてさらに詳細に説明するが、本発明の技術的範囲はこれによってなんら限定されるものではない。 Hereinafter, preparation examples of the plant extract of the genus Asclepiadaceae ( Cynanchuum ), tests for evaluating each action, formulation examples as external preparations for skin, and use tests will be described in more detail. The target range is not limited at all by this.

[調製方法1]
イケマ(Cynanchum caudatum (Miq.)Maxim.)の葉の乾燥粉砕物1kgに50質量%エタノール水溶液を20リットル加え、室温で7日間浸漬した。抽出液をろ過して回収し、溶媒を除去した後、ガガイモ科カモメヅル属植物抽出物30gを得た。
[Preparation Method 1]
20 kg of 50% ethanol aqueous solution was added to 1 kg of dry ground pulverized leaves of Ikema ( Cynanchum caudatum (Miq.) Maxim.) And immersed for 7 days at room temperature. The extract was collected by filtration, and after removing the solvent, 30 g of a genus Camellia plant extract was obtained.

[調製方法2]
イケマの葉の乾燥粉砕物1kgに水を20リットル加え、90℃にて6時間還流して抽出した。抽出液をろ過して回収し、溶媒を除去した後、ガガイモ科カモメヅル属植物抽出物20gを得た。
[Preparation Method 2]
20 kg of water was added to 1 kg of dried crushed leaves of Ikema and extracted by refluxing at 90 ° C. for 6 hours. The extract was collected by filtration and the solvent was removed, to obtain 20 g of the genus Camellia plant extract.

[調製方法3]
イケマ全草の乾燥粉砕物1kgにメタノール20リットル加え、室温で7日間浸漬した。抽出液をろ過して回収し、溶媒を除去した後、ガガイモ科カモメヅル属植物抽出物50gを得た。
[Preparation Method 3]
20 kg of methanol was added to 1 kg of dried crushed whole of Ikema and immersed for 7 days at room temperature. The extract was collected by filtration and the solvent was removed, and then 50 g of the genus Camellia plant extract was obtained.

[調製方法4]
超臨界抽出装置にイケマ全草の乾燥粉砕物100gを投入し、40℃において15Mpaの大気圧下で二酸化炭素の超臨界流体を用いて抽出した。抽出物を回収し、ガガイモ科カモメヅル属植物抽出物10gを得た。
[Preparation Method 4]
100 g of dried crushed whole Ikema plant was put into a supercritical extraction apparatus and extracted using a supercritical fluid of carbon dioxide at 40 ° C. under an atmospheric pressure of 15 Mpa. The extract was recovered to obtain 10 g of the extract of the plant belonging to the genus Gullaceae.

<抗老化作用(細胞賦活作用)の評価1>
ガガイモ科カモメヅル属植物抽出物の細胞賦活作用の評価を、以下に示す方法により行った。試料として、調製方法2により製造したガガイモ科カモメヅル属植物抽出物を用いた。
<Evaluation 1 of anti-aging action (cell activation action)>
Evaluation of the cell activation effect of the genus Camellia plant extract was performed by the method shown below. As the sample, the extract of the genus Camellia belonging to the genus Camellia belonging to the preparation method 2 was used.

クラボウ社(倉敷紡績株式会社)製正常ヒト真皮線維芽細胞を、1ウェル当たり2.0×10 個となるように96穴マイクロプレート播種した。播種培地には、ダルベッコ改変イーグル培地(DMEM)に1質量%のウシ胎児血清(FBS)を添加したものを用いた。24時間培養後、表2に示す各濃度となるように試料(抽出物)を添加した1質量%FBS添加DMEM培地に交換し、さらに48時間培養した。上清を除いた後、3−(4,5−ジメチル−2−チアゾリル)−2,5−ジフェニルテトラゾリウムブロミド(MTT)を400μg/mL含有する培地に交換して約2時間培養した。その後、テトラゾリウム環の開環により生じるフォルマザンを2−プロパノールにて抽出し、マイクロプレートリーダーにて550nmの吸光度を測定した。同時に、濁度として650nmにおける吸光度を測定し、両測定値の差により細胞賦活作用を評価した。評価では、試料を含む培地の他に、コントロールとして1質量%FBS添加DMEM培地を用いた。 Normal human dermal fibroblasts manufactured by Kurabo Industries Co., Ltd. (Kurashiki Boseki Co., Ltd.) were seeded in a 96-well microplate so as to be 2.0 × 10 4 cells per well. As the seeding medium, Dulbecco's modified Eagle medium (DMEM) to which 1% by mass of fetal bovine serum (FBS) was added was used. After culturing for 24 hours, the medium was replaced with 1% by mass FBS-added DMEM medium to which samples (extracts) were added so that the concentrations shown in Table 2 were obtained, and further cultured for 48 hours. After removing the supernatant, the medium was replaced with a medium containing 400 μg / mL of 3- (4,5-dimethyl-2-thiazolyl) -2,5-diphenyltetrazolium bromide (MTT) and cultured for about 2 hours. Thereafter, formazan produced by the opening of the tetrazolium ring was extracted with 2-propanol, and the absorbance at 550 nm was measured with a microplate reader. At the same time, the absorbance at 650 nm was measured as turbidity, and the cell activation effect was evaluated by the difference between the two measured values. In the evaluation, in addition to the medium containing the sample, 1% by mass FBS-added DMEM medium was used as a control.

評価結果を、コントロールにおける細胞賦活作用を100とした場合の相対値として表1に示す。   The evaluation results are shown in Table 1 as relative values when the cell activation effect in the control is 100.

Figure 2008255078
Figure 2008255078

表1より明らかなように、ガガイモ科カモメヅル属植物抽出物を添加した培地では、有意な細胞賦活効果が認められた。このことから、ガガイモ科カモメヅル属植物抽出物は、優れた細胞賦活作用を有することが明らかとなった。
<抗老化作用(コラーゲン産生促進作用)の評価2>
ガガイモ科カモメヅル属植物抽出物のコラーゲン産生促進作用の評価を、以下に示す方法により行った。試料として、調製方法2により製造したガガイモ科カモメヅル属植物抽出物を用いた。
As is clear from Table 1, a significant cell activation effect was observed in the medium to which the extract of the genus Camellia was added. From this, it was clarified that the extract of the genus Camellia belonging to the genus Camellia has an excellent cell activation effect.
<Evaluation 2 of anti-aging action (collagen production promoting action)>
Evaluation of the collagen production promoting action of the genus Camellia plant extract was performed by the following method. As the sample, the extract of the genus Camellia belonging to the genus Camellia belonging to the preparation method 2 was used.

クラボウ社(倉敷紡績株式会社)製正常ヒト真皮線維芽細胞を、1ウェル当たり2.0×10 個となるように96穴マイクロプレート播種した。播種培地には、ダルベッコ改変イーグル培地(DMEM)に5質量%のウシ胎児血清(FBS)を添加したものを用いた。24時間培養後、表7に示す各濃度となるように試料(抽出物)を添加した0.5質量%FBS添加DMEM培地に交換し、さらに24時間培養した。培養上清中に分泌されたタイプIコラーゲンの定量にはELISA法を用い、最後は標識されたペルオキシダーゼに対し2,2−アジノビス(3−エチルベンゾチアゾリン−6−スルホン酸)ジアンモニウム塩(ABTS)及び過酸化水素を添加し反応させた後、マイクロプレートリーダーにて405nmの吸光度を測定した。PIERCE社製BCA Protein Assay Kitにてタンパク量を測定し、単位タンパク量当りのタイプIコラーゲン産生量を求めた。 Normal human dermal fibroblasts manufactured by Kurabo Industries Co., Ltd. (Kurashiki Boseki Co., Ltd.) were seeded in a 96-well microplate so as to be 2.0 × 10 4 cells per well. The seeding medium used was Dulbecco's modified Eagle medium (DMEM) supplemented with 5% by weight fetal bovine serum (FBS). After culturing for 24 hours, the medium was replaced with 0.5% by mass FBS-added DMEM medium added with a sample (extract) so as to have each concentration shown in Table 7, and further cultured for 24 hours. The ELISA method was used for the quantification of type I collagen secreted into the culture supernatant, and finally 2,2-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) against labeled peroxidase. And hydrogen peroxide were added and reacted, and the absorbance at 405 nm was measured with a microplate reader. The amount of protein was measured with BCA Protein Assay Kit manufactured by PIERCE, and the amount of type I collagen produced per unit protein was determined.

評価結果を、試料無添加のコントロールにおける単位タンパク量当りのタイプIコラーゲン産生量を100とした時の相対値にて、表2に示す。   The evaluation results are shown in Table 2 as relative values when the amount of type I collagen produced per unit protein in the control without addition of the sample is 100.

Figure 2008255078
Figure 2008255078

表2より明らかなように、ガガイモ科カモメヅル属植物抽出物を添加した培地では、有意なコラーゲン産生促進効果が認められた。このことから、ガガイモ科カモメヅル属植物抽出物は、優れたコラーゲン産生促進作用を有することが明らかとなった。   As is clear from Table 2, a significant collagen production promoting effect was observed in the medium to which the extract of the genus Camellia was added. From this, it was clarified that the extract of the genus Camellia belonging to the genus Camellia has an excellent collagen production promoting action.

以上のことから、ガガイモ科カモメヅル属植物抽出物は、優れた抗老化作用を有することが明らかとなった。   From the above, it has been clarified that the extract of the genus Camellia spp. Has an excellent anti-aging effect.

<美白作用(チロシナーゼ活性阻害作用)の評価>
ガガイモ科カモメヅル属植物抽出物のチロシナーゼ活性阻害作用の評価を、以下に示す方法により行った。試料として、調製方法1により製造したガガイモ科カモメヅル属植物抽出物を用いた。
<Evaluation of whitening action (tyrosinase activity inhibitory action)>
Evaluation of the tyrosinase activity inhibitory action of the extract of the genus Camellia spp. Was performed by the following method. As the sample, the extract of the genus Camellia sp.

クラボウ社製正常ヒト表皮メラニン細胞を、1ウェル当たり3.0×10個となるように96ウェルマイクロプレートに播種した。播種培地には、クラボウ社製Medium154Sを用いた。24時間後、Medium154Sによって表3に示す各濃度に調整した試料添加培地に交換し、さらに48時間培養した。次に、1質量%Triton−X含有リン酸緩衝液75μLに交換して細胞を完全に溶解させ、内50μLを粗酵素液として使用した。粗酵素液に、基質となる0.05質量%L−ドーパ含有リン酸緩衝液50μLを加え、37℃で2時間静置した。マイクロプレートリーダーにより、基質添加直後と反応終了時の405nmの吸光度を測定し、生成されたドーパメラニン量を、式(1)に各測定値を導入して求めた。 Normal human epidermal melanocytes manufactured by Kurabo Industries Co., Ltd. were seeded in a 96-well microplate so as to be 3.0 × 10 4 cells per well. As a seeding medium, Medium154S manufactured by Kurabo Industries Co., Ltd. was used. After 24 hours, the medium was replaced with a sample-added medium adjusted to each concentration shown in Table 3 with Medium 154S, followed by further culturing for 48 hours. Next, the cells were completely lysed by exchanging with 75 μL of 1% by weight Triton-X-containing phosphate buffer, and 50 μL of the cells was used as a crude enzyme solution. To the crude enzyme solution, 50 μL of 0.05% by mass L-dopa-containing phosphate buffer serving as a substrate was added and allowed to stand at 37 ° C. for 2 hours. The absorbance at 405 nm was measured immediately after the addition of the substrate and at the end of the reaction with a microplate reader, and the amount of produced dopamelanin was determined by introducing each measured value into equation (1).

式(1):生成されたドーパメラニン量={(反応後405nm値−反応前405nm値)}−2.166/5.238
また、PIERCE社製BCA Protein Assay Kitにより各ウェルのタンパク量を測定し、単位タンパク量当たりのドーパメラニン生成量を求めた。
Formula (1): Amount of produced dopamelanin = {(405 nm value after reaction−405 nm value before reaction)} − 2.166 / 5.238
Moreover, the protein amount of each well was measured by BCA Protein Assay Kit made by PIERCE, and the amount of dopamelanin produced per unit protein amount was determined.

測定結果を、試料無添加の培地を用いたコントロールの値とともに表3に示す。   The measurement results are shown in Table 3 together with the values of the controls using the medium without the sample.

Figure 2008255078
Figure 2008255078

表3より明らかなように、ガガイモ科カモメヅル属植物抽出物を添加した培地を用いた場合には、メラニン産生量の低下が認められた。このことより、ガガイモ科カモメヅル属植物抽出物は、優れたチロシナーゼ活性阻害作用を有することがわかった。   As is clear from Table 3, when a medium supplemented with the extract of the genus Camellia was used, a decrease in melanin production was observed. From this, it was found that the extract of the genus Camellia belonging to the genus Gagaide has an excellent tyrosinase activity inhibitory action.

以上のことから、ガガイモ科カモメヅル属植物抽出物は、優れた美白作用を有することが明らかとなった。   From the above, it has been clarified that the extract of the genus Camellia belonging to the genus Camellia has an excellent whitening effect.

<抗酸化作用(ラジカル消去作用)の評価1>
ガガイモ科カモメヅル属植物抽出物の抗酸化作用の評価を、以下に示す方法により行った。試料として、調製方法2により製造したガガイモ科カモメヅル属植物抽出物を用いた。
<Evaluation of antioxidative action (radical scavenging action) 1>
Evaluation of the antioxidant activity of the extract of the genus Camellia spp. Was performed by the following method. As the sample, the extract of the genus Camellia belonging to the genus Camellia belonging to the preparation method 2 was used.

各試料を、50質量%エタノールを用いて濃度調整して試料溶液とし、表5に示す濃度となるように96穴マイクロプレートに100μLずつ添加した。そこへ、0.2mMの1,1−ジフェニル−2−ピクリルヒドラジカル(DPPH)エタノール溶液を100μLずつ添加し、良く混合後、室温、暗所にて24時間静置した。その後、DPPHラジカルに由来する516nmの吸光度を測定した。試料を添加しなかった場合のコントロールの吸光度を(A)、試料を添加した場合の吸光度を(B)としたとき、DPPHラジカルの消去率を式(2)に導入して求めた。測定結果を表4に示す。   The concentration of each sample was adjusted using 50% by mass ethanol to obtain a sample solution, and 100 μL each was added to a 96-well microplate so that the concentrations shown in Table 5 were obtained. Thereto was added 100 μL of 0.2 mM 1,1-diphenyl-2-picrylhydride radical (DPPH) ethanol solution, mixed well, and allowed to stand at room temperature in the dark for 24 hours. Thereafter, the absorbance at 516 nm derived from the DPPH radical was measured. When the absorbance of the control when the sample was not added was (A) and the absorbance when the sample was added was (B), the elimination rate of the DPPH radical was introduced into Equation (2) and obtained. Table 4 shows the measurement results.

式(2):ラジカル消去率={1−(B)/(A)}×100(%)       Formula (2): Radical scavenging rate = {1- (B) / (A)} × 100 (%)

Figure 2008255078
Figure 2008255078

表4より明らかなように、ガガイモ科カモメヅル属植物抽出物には優れたDPPHラジカルの消去効果が認められた。このことより、ガガイモ科カモメヅル属植物抽出物は、優れたラジカルの消去作用を有することがわかった。   As is clear from Table 4, an excellent DPPH radical scavenging effect was recognized in the genus Camellia plant extract. From this, it was found that the extract of the genus Camellia spp. Has an excellent radical scavenging action.

<抗酸化作用(スーパーオキサイドアニオン消去作用)の評価2>
ガガイモ科カモメヅル属植物抽出物のスーパーオキサイドアニオン消去作用の評価を、以下に示す方法により行った。試料として、調製方法2により製造したガガイモ科カモメヅル属植物抽出物を用いた。
<Evaluation 2 of Antioxidant Action (Superoxide Anion Scavenging Action)>
Evaluation of the superoxide anion scavenging action of the genus Camellia plant extract was performed by the following method. As the sample, the extract of the genus Camellia belonging to the genus Camellia belonging to the preparation method 2 was used.

0.25mM WST−1及び1mM Hypoxanthineを含むHanks(+)溶液75μLに、表6に示す濃度となるようにHanks(+)溶液で希釈した試料25μLを添加し、Xanthine Oxidase25μL(0.0075Units)を加え、37℃で15分間反応後、450nmの吸光度を測定した。試料が無添加のコントロールの吸光度を(A)、試料を添加したときの吸光度を(B)としたとき、式(3)の値をスーパーオキサイドアニオン消去率とした。評価結果を表5に示した。   To 75 μL of Hanks (+) solution containing 0.25 mM WST-1 and 1 mM Hypoxanthine, 25 μL of a sample diluted with Hanks (+) solution to a concentration shown in Table 6 was added, and 25 μL of Xanthine Oxidase (0.0075 Units) was added. In addition, after reacting at 37 ° C. for 15 minutes, absorbance at 450 nm was measured. When the absorbance of the control with no sample added was (A) and the absorbance when the sample was added was (B), the value of formula (3) was defined as the superoxide anion elimination rate. The evaluation results are shown in Table 5.

式(3):消去率={1−(B)/(A)}×100(%)       Formula (3): Erase rate = {1- (B) / (A)} × 100 (%)

Figure 2008255078
Figure 2008255078

表5より明らかなように、ガガイモ科カモメヅル属植物抽出物には優れたスーパーオキサイドアニオンの消去効果が認められた。このことより、ガガイモ科カモメヅル属植物抽出物は、優れたスーパーオキサイドアニオンの消去作用を有することがわかった。   As is clear from Table 5, the superoxide anion scavenging effect was recognized excellent in the genus Camellia plant extract. From this, it was found that the extract of the genus Camellia belonging to the genus Camellia has an excellent superoxide anion scavenging action.

以上のことから、ガガイモ科カモメヅル属植物抽出物は、優れた抗酸化作用を有することが明らかとなった。   From the above, it has been clarified that the extract of the genus Camellia spp.

<痩身作用(中性脂肪蓄積抑制作用)の評価>
ガガイモ科カモメヅル属植物抽出物の脂肪細胞における中性脂肪蓄積抑制作用の評価を、以下に示す方法により行った。試料として、調製方法1により製造したガガイモ科カモメヅル属植物抽出物を用いた。
<Evaluation of slimming action (inhibition of neutral fat accumulation)>
Evaluation of the neutral fat accumulation inhibitory action in the adipocytes of the genus Camellia plant extract was performed by the following method. As the sample, the extract of the genus Camellia sp.

皮下脂肪由来正常ヒト前駆脂肪細胞Cryo・HPRAD−SQ(三光純薬株式会社)を、1ウェル当り1.0×104 個となるように96ウェルマイクロプレートに播種した。播種培地には、PGM培地(10質量%ウシ胎児血清(FBS),2mM L−Glutamine,100units/mL Penicilline,100μg/mL Streptomycine含有)を用いた。細胞が飽和状態になる直前に表4に示す濃度の試料を添加したPGM分化用培地(10μg/mL インシュリン,1μM Dexamethasone,200μM Indomethacin,500μM Isobutyl−methylxanthine含有)に交換し、脂肪細胞への分化誘導を行った。分化誘導開始後、コントロール群が成熟して細胞内に多数の脂肪滴が蓄積されるまで、10日〜14日間培養した。細胞を回収後、10%中性緩衝ホルムアルデヒド液を用いて細胞を固定した。PBSにて洗浄の後、0.5w/v%オイルレッドO溶液を添加し、37℃で2時間インキュベートした。PBSにて洗浄の後、メタノールを添加し、色素を抽出した。抽出後、マイクロプレートリーダーより、550nmの吸光度を測定した。同時に、濁度として650nmの吸光度を測定し、両測定値の差を用いて中性脂肪蓄積量を測定した。 Subcutaneous fat-derived normal human preadipocytes Cryo • HPRAD-SQ (Sanko Junyaku Co., Ltd.) were seeded on a 96-well microplate so that the number was 1.0 × 10 4 per well. PGM medium (containing 10% by mass fetal bovine serum (FBS), 2 mM L-Glutamine, 100 units / mL Penicilline, 100 μg / mL Streptomycine) was used as the seeding medium. Immediately before the cells are saturated, the medium is changed to PGM differentiation medium (containing 10 μg / mL insulin, 1 μM Dexamethasone, 200 μM Indomethacin, 500 μM Isobutyl-methylxanthine) to which the samples shown in Table 4 are added, and induction of differentiation into adipocytes Went. After initiation of differentiation induction, the cells were cultured for 10 to 14 days until the control group matured and many lipid droplets accumulated in the cells. After the cells were collected, the cells were fixed using a 10% neutral buffered formaldehyde solution. After washing with PBS, 0.5 w / v% Oil Red O solution was added and incubated at 37 ° C. for 2 hours. After washing with PBS, methanol was added to extract the dye. After extraction, the absorbance at 550 nm was measured from a microplate reader. At the same time, the absorbance at 650 nm was measured as turbidity, and the amount of accumulated triglyceride was measured using the difference between the two measured values.

測定結果を、試料無添加の培地を用いたコントロールにおける、中性脂肪蓄積量を100とした相対値により、表6に示す。   The measurement results are shown in Table 6 in terms of relative values with the neutral fat accumulation amount being 100 in the control using the medium without the sample.

Figure 2008255078
Figure 2008255078

表6より明らかなように、ガガイモ科カモメヅル属植物抽出物を添加した培地では、有意な中性脂肪蓄積抑制効果が認められた。このことから、ガガイモ科カモメヅル属植物抽出物は、優れた中性脂肪蓄積抑制作用を有することが明らかとなった。   As is clear from Table 6, a significant neutral fat accumulation inhibitory effect was observed in the medium to which the extract of the genus Camellia was added. From this, it was clarified that the extract of the genus Camellia spp.

以上のことから、ガガイモ科カモメヅル属植物抽出物は、優れた痩身作用を有することが明らかとなった。   From the above, it was clarified that the extract of the genus Camellia belonging to the genus Camellia has an excellent slimming action.

<アルギナーゼ活性促進作用の評価>
ガガイモ科カモメヅル属植物抽出物のアルギナーゼ活性促進作用の評価を、以下に示す方法により行った。試料として、調製方法1により製造したガガイモ科カモメヅル属植物抽出物を用いた。
<Evaluation of arginase activity promoting action>
Evaluation of the arginase activity promoting action of the genus Camellia plant extract was carried out by the following method. As the sample, the extract of the genus Camellia sp.

ヒト表皮角化細胞HaCaTを1ウェル当り2.0×10 個となるように96ウェルマイクロプレートに播種した。播種培地には5質量%のウシ胎児血清(FBS)を添加したダルベッコ改変イーグル培地を用いた。24時間培養後、表1示す各濃度となるように試料(抽出物)を添加した1.2mMCaCl を含む5質量%FBS添加分化誘導培地に交換し、さらに9日間培養した。培地交換は3日に1回のペースで行った。培養上清中に分泌された尿素の定量には、尿素窒素B−テストワコー(和光純薬)を用いた。アルギナーゼはアルギニンを加水分解し、オルニチン、尿素を生成する。尿素はウレアーゼによってアンモニアに分解され、アンモニアはペンタシアノニトロリル鉄(III)酸ナトリウムニ水和物存在下でサリチル酸、次亜塩素酸と反応しインドフェノールとなる。アルカリ性条件下、マイクロプレートリーダーでインドフェノールに由来する570nmの吸光度を測定し、尿素濃度を求め、アルギナーゼ活性の定量を行った。PIERCE社製BCA Protein Assay Kitにてタンパク量を測定し、単位タンパク量当りのアルギナーゼ活性を求めた。 Human epidermal keratinocytes HaCaT were seeded in a 96-well microplate so as to be 2.0 × 10 4 cells per well. Dulbecco's modified Eagle medium supplemented with 5% by weight fetal bovine serum (FBS) was used as the seeding medium. After culturing for 24 hours, the culture medium was replaced with a 5% by mass FBS-added differentiation-inducing medium containing 1.2 mM CaCl 2 added with a sample (extract) so as to have each concentration shown in Table 1, and further cultured for 9 days. The medium was exchanged once every 3 days. Urea nitrogen B-Test Wako (Wako Pure Chemical Industries) was used for quantification of urea secreted into the culture supernatant. Arginase hydrolyzes arginine to produce ornithine and urea. Urea is decomposed into ammonia by urease, and ammonia reacts with salicylic acid and hypochlorous acid in the presence of sodium pentacyanonitrolyl iron (III) dihydrate to form indophenol. Under alkaline conditions, the absorbance at 570 nm derived from indophenol was measured with a microplate reader, the urea concentration was determined, and the arginase activity was quantified. The amount of protein was measured with BCA Protein Assay Kit manufactured by PIERCE, and the arginase activity per unit protein amount was determined.

評価結果を、試料無添加のコントロールにおける単位タンパク量当りのアルギナーゼ活性を100とした時の相対値として、表7に示す。   The evaluation results are shown in Table 7 as relative values when the arginase activity per unit protein amount in the control with no sample added is defined as 100.

Figure 2008255078
Figure 2008255078

表7より明らかなように、ガガイモ科カモメヅル属植物抽出物を添加した培地では、有意なアルギナーゼ活性促進効果が認められた。このことから、ガガイモ科カモメヅル属植物抽出物は、優れたアルギナーゼ活性促進作用を有することが明らかとなった。   As is clear from Table 7, a significant arginase activity promoting effect was observed in the medium to which the extract of the genus Camellia was added. From this, it was clarified that the extract of the genus Camellia belonging to the genus Gagaide has an excellent arginase activity promoting action.

続いて、上記各調製方法で得られたガガイモ科カモメヅル属植物抽出物を配合した皮膚外用剤の処方例を示す。   Then, the formulation example of the external preparation for skin which mix | blended the genus Camellia genus plant extract obtained by said each preparation method is shown.

[実施例1]乳液
(1) スクワラン 10.0(質量%)
(2) メチルフェニルポリシロキサン 4.0
(3) 水素添加パーム核油 0.5
(4) 水素添加大豆リン脂質 0.1
(5) モノステアリン酸ポリオキシエチレン
ソルビタン(20E.O.) 1.3
(6) モノステアリン酸ソルビタン 1.0
(7) グリセリン 4.0
(8) パラオキシ安息香酸メチル 0.1
(9) カルボキシビニルポリマー 0.15
(10)精製水 100とする残部
(11)アルギニン(1質量%水溶液) 20.0
(12)ガガイモ科カモメヅル属植物抽出物[調製方法1] 5.0
製法:(1)〜(6)の油相成分を80℃にて加熱溶解する。一方(7)〜(10)の水相成分を80℃にて加熱溶解する。これに前記油相成分を攪拌しながら加え、ホモジナイザーにより均一に乳化する。乳化終了後、冷却を開始し、(11)と(12)を順次加え、均一に混合する。
[Example 1] Emulsion (1) Squalane 10.0 (mass%)
(2) Methylphenylpolysiloxane 4.0
(3) Hydrogenated palm kernel oil 0.5
(4) Hydrogenated soybean phospholipid 0.1
(5) Polyoxyethylene monostearate
Sorbitan (20E.O.) 1.3
(6) Sorbitan monostearate 1.0
(7) Glycerin 4.0
(8) Methyl paraoxybenzoate 0.1
(9) Carboxyvinyl polymer 0.15
(10) Purified water 100 (11) Arginine (1% by weight aqueous solution) 20.0
(12) Sea urchin family gull genus plant extract [Preparation method 1] 5.0
Production method: The oil phase components (1) to (6) are heated and dissolved at 80 ° C. On the other hand, the aqueous phase components (7) to (10) are dissolved by heating at 80 ° C. The oil phase component is added to this while stirring and uniformly emulsified with a homogenizer. After the emulsification, cooling is started, and (11) and (12) are sequentially added and mixed uniformly.

[実施例2]化粧水
(1)エタノール 15.0(質量%)
(2)ポリオキシエチレン(40E.O.)硬化ヒマシ油 0.3
(3)香料 0.1
(4)精製水 100とする残部
(5)クエン酸 0.02
(6)クエン酸ナトリウム 0.1
(7)グリセリン 1.0
(8)ヒドロキシエチルセルロース 0.1
(9)ガガイモ科カモメヅル属植物抽出物[調製方法3] 1.0
製法:(1)に(2)及び(3)を溶解する。溶解後、(4)〜(8)を順次添加した後、十分に攪拌し、(9)を加え、均一に混合する。
[Example 2] Lotion (1) Ethanol 15.0 (mass%)
(2) Polyoxyethylene (40E.O.) hydrogenated castor oil 0.3
(3) Fragrance 0.1
(4) Purified water 100 (5) Citric acid 0.02
(6) Sodium citrate 0.1
(7) Glycerin 1.0
(8) Hydroxyethyl cellulose 0.1
(9) An extract of the genus Camellia spp. [Preparation method 3] 1.0
Production method: (2) and (3) are dissolved in (1). After dissolution, (4) to (8) are sequentially added, and then sufficiently stirred, (9) is added and mixed uniformly.

[実施例3]クリーム
(1) スクワラン 10.0(質量%)
(2) ステアリン酸 2.0
(3) 水素添加パーム核油 0.5
(4) 水素添加大豆リン脂質 0.1
(5) セタノール 3.6
(6) 親油型モノステアリン酸グリセリン 2.0
(7) グリセリン 10.0
(8) パラオキシ安息香酸メチル 0.1
(9) アルギニン(20質量%水溶液) 15.0
(10)精製水 100とする残部
(11)カルボキシビニルポリマー(1質量%水溶液) 15.0
(12)ガガイモ科カモメヅル属植物抽出物[調製方法1] 5.0
製法:(1)〜(6)の油相成分を80℃にて加熱溶解する。一方(7)〜(10)の水相成分を80℃にて加熱溶解する。これに前記油相成分を攪拌しながら加え、ホモジナイザーにより均一に乳化する。乳化終了後、(11)を加え、冷却を開始し、40℃にて(12)を加え、均一に混合する。
[Example 3] Cream (1) Squalane 10.0 (mass%)
(2) Stearic acid 2.0
(3) Hydrogenated palm kernel oil 0.5
(4) Hydrogenated soybean phospholipid 0.1
(5) Cetanol 3.6
(6) Lipophilic glyceryl monostearate 2.0
(7) Glycerin 10.0
(8) Methyl paraoxybenzoate 0.1
(9) Arginine (20 mass% aqueous solution) 15.0
(10) Remainder 100 (11) Carboxyvinyl polymer (1% by weight aqueous solution) 15.0
(12) Sea urchin family gull genus plant extract [Preparation method 1] 5.0
Production method: The oil phase components (1) to (6) are heated and dissolved at 80 ° C. On the other hand, the aqueous phase components (7) to (10) are dissolved by heating at 80 ° C. The oil phase component is added to this while stirring and uniformly emulsified with a homogenizer. (11) is added after completion | finish of emulsification, cooling is started, (12) is added at 40 degreeC, and it mixes uniformly.

[実施例4]美容液
(1) 精製水 100とする残部(質量%)
(2) グリセリン 10.0
(3) ショ糖脂肪酸エステル 1.3
(4) カルボキシビニルポリマー(1質量%水溶液) 17.5
(5) アルギン酸ナトリウム(1質量%水溶液) 15.0
(6) モノラウリン酸ポリグリセリル 1.0
(7) マカデミアナッツ油脂肪酸フィトステリル 3.0
(8) N−ラウロイル−L−グルタミン酸
ジ(フィトステリル−2−オクチルドデシル) 2.0
(9) 硬化パーム油 2.0
(10)スクワラン(オリーブ由来) 1.0
(11)ベヘニルアルコール 0.75
(12)ミツロウ 1.0
(13)ホホバ油 1.0
(14)1,3−ブチレングリコール 10.0
(15)L−アルギニン(10重量%水溶液) 2.0
(16)ガガイモ科カモメヅル属植物抽出物[調製方法2] 3.0
製法:(1)〜(6)の水相成分を混合し、75℃にて加熱溶解する。一方、(7)〜(14)の油相成分を混合し、75℃にて加熱溶解する。次いで、上記水相成分に油相成分を添加して予備乳化を行った後、ホモミキサーにて均一に乳化する。乳化終了後に冷却を開始し、50℃にて(15)を加える。さらに40℃まで冷却し、(16)を加え、均一に混合する。
[Example 4] Cosmetic liquid (1) The balance (mass%) of purified water 100
(2) Glycerin 10.0
(3) Sucrose fatty acid ester 1.3
(4) Carboxyvinyl polymer (1% by weight aqueous solution) 17.5
(5) Sodium alginate (1% by weight aqueous solution) 15.0
(6) Polyglyceryl monolaurate 1.0
(7) Macadamia nut oil fatty acid phytosteryl 3.0
(8) N-lauroyl-L-glutamic acid di (phytosteryl-2-octyldodecyl) 2.0
(9) Hardened palm oil 2.0
(10) Squalane (derived from olive) 1.0
(11) Behenyl alcohol 0.75
(12) Beeswax 1.0
(13) Jojoba oil 1.0
(14) 1,3-butylene glycol 10.0
(15) L-arginine (10% by weight aqueous solution) 2.0
(16) An extract of the genus Camellia spp. [Preparation Method 2] 3.0
Production method: The aqueous phase components (1) to (6) are mixed and dissolved by heating at 75 ° C. On the other hand, the oil phase components (7) to (14) are mixed and dissolved by heating at 75 ° C. Next, the oil phase component is added to the aqueous phase component and preliminary emulsification is performed, followed by uniform emulsification with a homomixer. Cooling is started after completion of emulsification, and (15) is added at 50 ° C. Cool further to 40 ° C., add (16) and mix evenly.

[実施例5]水性ジェル
(1) カルボキシビニルポリマー 0.5(質量%)
(2) 精製水 100とする残部
(3) 水酸化ナトリウム(10質量%水溶液) 0.5
(4) エタノール 10.0
(5) パラオキシ安息香酸メチル 0.1
(6) 香料 0.1
(7) ガガイモ科カモメヅル属植物抽出物[調製方法2] 0.5
(8) ポリオキシエチレン(60E.O.)硬化ヒマシ油 1.0
製法:(1)を(2)に加え、均一に攪拌した後、(3)を加える。均一に攪拌した後、(4)に予め溶解した(5)を加える。均一に攪拌した後、予め混合しておいた(6)〜(8)を加え、均一に攪拌混合する。
[Example 5] Aqueous gel (1) Carboxyvinyl polymer 0.5 (mass%)
(2) The remainder (3) made into purified water 100 (3) Sodium hydroxide (10 mass% aqueous solution) 0.5
(4) Ethanol 10.0
(5) Methyl paraoxybenzoate 0.1
(6) Fragrance 0.1
(7) Extract from the genus Camellia family [Preparation method 2] 0.5
(8) Polyoxyethylene (60E.O.) hydrogenated castor oil 1.0
Manufacturing method: (1) is added to (2), and after stirring uniformly, (3) is added. After stirring uniformly, (5) previously dissolved in (4) is added. After stirring uniformly, the previously mixed (6) to (8) are added and stirred and mixed uniformly.

[実施例6]クレンジング料
(1) スクワラン 81.0(質量%)
(2) イソステアリン酸ポリオキシエチレングリセリル 15.0
(3) 精製水 100とする残部
(4) ガガイモ科カモメヅル属植物抽出物[調製方法3] 4.0
製法:(1)と(2)を均一に溶解する。これに、(3)と(4)を順次加え、均一に混合する。
[Example 6] Cleansing fee (1) Squalane 81.0 (mass%)
(2) Polyoxyethylene glyceryl isostearate 15.0
(3) Remainder as purified water 100 (4) Extract from the genus Gullaceae [Preparation method 3] 4.0
Manufacturing method: (1) and (2) are uniformly dissolved. (3) and (4) are sequentially added to this and mixed uniformly.

[実施例7]洗顔フォーム
(1) ステアリン酸 16.0(質量%)
(2) ミリスチン酸 16.0
(3) 親油型モノステアリン酸グリセリン 2.0
(4) グリセリン 25.0
(5) 水酸化ナトリウム 7.5
(6) ヤシ油脂肪酸アミドプロピルベタイン 1.0
(7) 精製水 100とする残部
(8) ガガイモ科カモメヅル属植物抽出物[調製方法3] 0.1
製法:(1)〜(4)の油相成分を80℃にて加熱溶解する。一方(5)〜(7)の水相成分を80℃にて加熱溶解し、油相成分と均一に混合撹拌する。冷却を開始し、40℃にて(8)を加え、均一に混合する。
[Example 7] Face-wash foam (1) Stearic acid 16.0 (mass%)
(2) Myristic acid 16.0
(3) Lipophilic glyceryl monostearate 2.0
(4) Glycerin 25.0
(5) Sodium hydroxide 7.5
(6) Palm oil fatty acid amidopropyl betaine 1.0
(7) The remainder (8) made from purified water 100 (Extracted from the genus Camellia) [Preparation method 3] 0.1
Production method: The oil phase components (1) to (4) are heated and dissolved at 80 ° C. On the other hand, the aqueous phase components (5) to (7) are heated and dissolved at 80 ° C., and mixed and stirred uniformly with the oil phase components. Cooling is started, and (8) is added at 40 ° C. and mixed uniformly.

[実施例8]メイクアップベースクリーム
(1) スクワラン 10.2(質量%)
(2) セタノール 2.0
(3) グリセリントリ−2−エチルヘキサン酸エステル 2.5
(4) 親油型モノステアリン酸グリセリル 1.0
(5) プロピレングリコール 11.0
(6) ショ糖脂肪酸エステル 1.3
(7) 精製水 100とする残部
(8) 酸化チタン 1.0
(9) ベンガラ 0.1
(10)黄酸化鉄 0.4
(11)香料 0.1
(12)ガガイモ科カモメヅル属植物抽出物[調製方法2] 3.0
製法:(1)〜(4)の油相成分を混合し、75℃にて加熱溶解する。一方、(5)〜(7)の水相成分を混合し、75℃にて加熱溶解し、これに(8)〜(10)の顔料を加え、ホモミキサーにて均一に分散させる。この水相成分に前記油相成分を加え、ホモミキサーにて乳化する。乳化終了後に冷却を開始し、40℃にて(11)と(12)の成分を加え、均一に混合する。
[Example 8] Make-up base cream (1) Squalane 10.2 (% by mass)
(2) Cetanol 2.0
(3) Glycerin tri-2-ethylhexanoate 2.5
(4) Lipophilic glyceryl monostearate 1.0
(5) Propylene glycol 11.0
(6) Sucrose fatty acid ester 1.3
(7) The balance (100) of purified water 100 (titanium oxide) 1.0
(9) Bengala 0.1
(10) Yellow iron oxide 0.4
(11) Fragrance 0.1
(12) Extract from the genus Gullaceae [Preparation Method 2] 3.0
Production method: The oil phase components (1) to (4) are mixed and dissolved by heating at 75 ° C. On the other hand, the aqueous phase components (5) to (7) are mixed, dissolved by heating at 75 ° C., the pigments (8) to (10) are added thereto, and the mixture is uniformly dispersed with a homomixer. The oil phase component is added to the water phase component and emulsified with a homomixer. Cooling is started after the emulsification is completed, and the components (11) and (12) are added at 40 ° C. and mixed uniformly.

[実施例9]乳液状ファンデーション
(1) メチルポリシロキサン 2.0(質量%)
(2) スクワラン 5.0
(3) ミリスチン酸オクチルドデシル 5.0
(4) セタノール 1.0
(5) ポリオキシエチレン(20E.O.)
ソルビタンモノステアリン酸エステル 1.3
(6) モノステアリン酸ソルビタン 0.7
(7) 1,3−ブチレングリコール 8.0
(8) キサンタンガム 0.1
(9) パラオキシ安息香酸メチル 0.1
(10)精製水 100とする残部
(11)酸化チタン 9.0
(12)タルク 7.4
(13)ベンガラ 0.5
(14)黄酸化鉄 1.1
(15)黒酸化鉄 0.1
(16)香料 0.1
(17)ガガイモ科カモメヅル属植物抽出物[調製方法1] 0.5
製法:(1)〜(6)の油相成分を混合し、75℃にて加熱溶解する。一方、(7)〜(10)の水相成分を混合し、75℃にて加熱溶解し、これに(11)〜(15)の顔料を加え、ホモミキサーにて均一に分散する。油相成分を加え、乳化を行う。乳化終了後に冷却を開始し、40℃にて(16)と(17)の成分を順次加え、均一に混合する。
[Example 9] Emulsion foundation (1) Methylpolysiloxane 2.0 (mass%)
(2) Squalane 5.0
(3) Octyldodecyl myristate 5.0
(4) Cetanol 1.0
(5) Polyoxyethylene (20E.O.)
Sorbitan monostearate 1.3
(6) Sorbitan monostearate 0.7
(7) 1,3-butylene glycol 8.0
(8) Xanthan gum 0.1
(9) Methyl paraoxybenzoate 0.1
(10) Remainder water 100 (11) Titanium oxide 9.0
(12) Talc 7.4
(13) Bengala 0.5
(14) Yellow iron oxide 1.1
(15) Black iron oxide 0.1
(16) Fragrance 0.1
(17) Sea urchin family gull genus plant extract [Preparation method 1] 0.5
Production method: The oil phase components (1) to (6) are mixed and dissolved by heating at 75 ° C. On the other hand, the aqueous phase components (7) to (10) are mixed and dissolved by heating at 75 ° C., and the pigments (11) to (15) are added thereto and uniformly dispersed with a homomixer. Add oil phase ingredients and emulsify. Cooling is started after the emulsification is completed, and the components (16) and (17) are sequentially added at 40 ° C. and mixed uniformly.

[実施例10]油中水型エモリエントクリーム
(1) 流動パラフィン 34.0(質量%)
(2) マイクロクリスタリンワックス 2.0
(3) ワセリン 5.0
(4) ジグリセリンオレイン酸エステル 5.0
(5) 塩化ナトリウム 1.3
(6) 塩化カリウム 0.1
(7) プロピレングリコール 3.0
(8) 1,3−ブチレングリコール 5.0
(9) パラオキシ安息香酸メチル 0.1
(10)ガガイモ科カモメヅル属植物抽出物[調製方法1] 3.0
(11)精製水 100とする残部
(12)香料 0.1
製法:(5)と(6)を(11)の一部に溶解して50℃とし、50℃に加熱した(4)に撹拌しながら徐々に加える。これを混合した後、70℃にて加熱溶解した(1)〜(3)に均一に分散する。これに(7)〜(10)を(11)の残部に70℃にて加熱溶解したものを撹拌しながら加え、ホモミキサーにて乳化する。乳化終了後に冷却を開始し、40℃にて(12)を加え、均一に混合する。
[Example 10] Water-in-oil emollient cream (1) Liquid paraffin 34.0 (mass%)
(2) Microcrystalline wax 2.0
(3) Vaseline 5.0
(4) Diglycerin oleate 5.0
(5) Sodium chloride 1.3
(6) Potassium chloride 0.1
(7) Propylene glycol 3.0
(8) 1,3-butylene glycol 5.0
(9) Methyl paraoxybenzoate 0.1
(10) An extract of the genus Camellia spp. [Preparation Method 1] 3.0
(11) The balance of 100 purified water (12) Fragrance 0.1
Production method: Dissolve (5) and (6) in a part of (11) to 50 ° C., and gradually add to (4) heated to 50 ° C. with stirring. After mixing this, it disperse | distributes uniformly to (1)-(3) heated and melted at 70 degreeC. (7) to (10) are added to the remainder of (11) heated and dissolved at 70 ° C. with stirring, and emulsified with a homomixer. Cooling is started after completion of emulsification, and (12) is added at 40 ° C. and mixed uniformly.

[実施例11]パック
(1) 精製水 100とする残部(質量%)
(2) ポリビニルアルコール 12.0
(3) エタノール 17.0
(4) グリセリン 9.0
(5) ポリエチレングリコール(平均分子量1000) 2.0
(6) ガガイモ科カモメヅル属植物抽出物[調製方法2] 1.0
(7) 香料 0.1
製法:(2)と(3)を混合し、80℃に加温した後、80℃に加温した(1)に溶解する。均一に溶解した後、(4)と(5)を加え、攪拌しながら冷却を開始する。40℃まで冷却し、(6)と(7)を加え、均一に混合する。
[Example 11] Pack (1) The balance (mass%) of purified water 100
(2) Polyvinyl alcohol 12.0
(3) Ethanol 17.0
(4) Glycerin 9.0
(5) Polyethylene glycol (average molecular weight 1000) 2.0
(6) Species of the genus Camellia family [Preparation method 2] 1.0
(7) Fragrance 0.1
Production method: (2) and (3) are mixed, heated to 80 ° C, and then dissolved in (1) heated to 80 ° C. After uniformly dissolving, add (4) and (5), and start cooling while stirring. Cool to 40 ° C, add (6) and (7) and mix uniformly.

[実施例12]入浴剤
(1) 香料 0.3(質量%)
(2) ガガイモ科カモメヅル属植物抽出物[調製方法3] 3.0
(3) 炭酸水素ナトリウム 50.0
(4) 硫酸ナトリウム 46.7
製法:(1)〜(4)を均一に混合する。
[Example 12] Bath agent (1) Fragrance 0.3 (mass%)
(2) Extract from the genus Gullaceae [Preparation method 3] 3.0
(3) Sodium bicarbonate 50.0
(4) Sodium sulfate 46.7
Production method: (1) to (4) are mixed uniformly.

[実施例13]ヘアーワックス
(1) ステアリン酸 3.0(質量%)
(2) マイクロクリスタリンワックス 2.0
(3) セチルアルコール 3.0
(4) 高重合メチルポリシロキサン 2.0
(5) メチルポリシロキサン 5.0
(6) ポリ(オキシエチレン・オキシプロピレン)
メチルポリシロキサン共重合体 1.0
(7) パラオキシ安息香酸メチル 0.1
(8) 1,3−ブチレングリコール 7.5
(9) アルギニン 0.7
(10)精製水 100とする残部
(11)ガガイモ科カモメヅル属植物抽出物[調製方法3] 2.0
(12)香料 0.1
製法:(1)〜(6)の油相成分を混合し、75℃にて加熱溶解後する。一方、(7)〜(10)の水相成分を75℃にて加熱溶解し、前記油相成分を加え、ホモミキサーにて乳化する。乳化終了後に冷却を開始し、40℃にて(11)と(12)の成分を加え、均一に混合する。
[Example 13] Hair wax (1) Stearic acid 3.0 (mass%)
(2) Microcrystalline wax 2.0
(3) Cetyl alcohol 3.0
(4) Highly polymerized methylpolysiloxane 2.0
(5) Methylpolysiloxane 5.0
(6) Poly (oxyethylene / oxypropylene)
Methylpolysiloxane copolymer 1.0
(7) Methyl paraoxybenzoate 0.1
(8) 1,3-butylene glycol 7.5
(9) Arginine 0.7
(10) Purified water, the remainder (100) (11) Species of the genus Gullaceae [Preparation method 3] 2.0
(12) Fragrance 0.1
Production method: The oil phase components (1) to (6) are mixed and heated and dissolved at 75 ° C. On the other hand, the aqueous phase components (7) to (10) are dissolved by heating at 75 ° C., the oil phase component is added, and the mixture is emulsified with a homomixer. Cooling is started after the emulsification is completed, and the components (11) and (12) are added at 40 ° C. and mixed uniformly.

[実施例14]ヘアートニック
(1) エタノール 50.0(質量%)
(2) 精製水 100とする残部
(3) ガガイモ科カモメヅル属植物抽出物[調製方法1] 3.0
(4) 香料 0.1
製法:(1)〜(4)の成分を混合、均一化する。
[Example 14] Hair artic (1) Ethanol 50.0 (mass%)
(2) Purified water, the remainder (100) (3) Species of the genus Gullaceae [Preparation method 1] 3.0
(4) Fragrance 0.1
Production method: Components (1) to (4) are mixed and homogenized.

<保湿作用の評価>
実施例1、3の皮膚外用剤を用いた使用試験を行い、ガガイモ科カモメヅル属植物抽出物の保湿性について評価した。その際、実施例1において配合したガガイモ科カモメヅル属植物抽出物を、50%質量エタノール水溶液に代えたものを比較例1、実施例3において配合したガガイモ科カモメヅル属植物抽出物を、50%質量エタノール水溶液に代えたものを比較例2として、同様に使用試験を行った。
<Evaluation of moisturizing action>
A use test using the external preparation for skin of Examples 1 and 3 was performed, and the moisture retention of the genus Gullaceae plant extract was evaluated. At that time, the extract of the genus Camellia belonging to the genus Camellia belonging to Example 1 was replaced with 50% by mass ethanol aqueous solution, and the extract of the genus Camellia belonging to the genus Camellia belonging to Example 1 was compared with 50% by mass A usage test was conducted in the same manner as Comparative Example 2 except that the ethanol aqueous solution was used.

男女パネラー15名を一群として各試料をブラインドにてそれぞれ1か月間使用させ、「感じる」、「どちらともいえない」、「感じない」の三段階で評価した。表8に、各評価を得たパネラー数を示す。   A group of 15 male and female panelists were allowed to use each sample blindly for one month, and evaluated in three stages: “feel”, “cannot say”, and “do not feel”. Table 8 shows the number of panelists that obtained each evaluation.

Figure 2008255078
Figure 2008255078

表8より、ガガイモ科カモメヅル属植物抽出物を配合した実施例使用群においては、80%以上のパネラーに明確な保湿性が感じられることがわかった。このことから、ガガイモ科カモメヅル属植物抽出物は、優れた保湿作用を有することが明らかとなった。   From Table 8, it was found that 80% or more of panelists could feel clear moisture retention in the use group of Examples blended with the extract of the genus Camellia. From this, it was clarified that the extract of the genus Camellia spp. Has an excellent moisturizing action.

<トリートメント作用の評価)>
実施例1、3及び比較例1、2の皮膚外用剤を用いた使用試験を行い、肌荒れ、肌のキメ、肌の透明感について、それらの症状の改善効果を評価した。
<Evaluation of treatment action>
The use test using the skin external preparations of Examples 1 and 3 and Comparative Examples 1 and 2 was conducted, and the improvement effect of those symptoms was evaluated with respect to rough skin, skin texture, and skin transparency.

各試料について、肌荒れ、肌のキメ、肌の透明感について悩みを持つ20〜50才代の男女パネラー20名を一群とし、ブラインドにてそれぞれ1か月間使用させ、使用前後の皮膚状態の変化を観察して評価した。皮膚状態の指標として、肌荒れ、肌のキメ、肌の透明感について、「改善」、「やや改善」、「変化なし」の三段階で評価した。肌荒れと肌の透明感は目視にて評価し、肌のキメはマイクロスコープを用いて観察した。表9に各評価を得たパネラー数を示す。   For each sample, a group of 20 male and female panelists in their 20s to 50s who are worried about rough skin, skin texture, and skin transparency are used for 1 month each blind, and changes in skin condition before and after use. Observed and evaluated. As indicators of skin condition, rough skin, skin texture, and skin transparency were evaluated in three stages: “Improved”, “Slightly improved”, and “No change”. The rough skin and the transparency of the skin were visually evaluated, and the texture of the skin was observed using a microscope. Table 9 shows the number of panelists that obtained each evaluation.

Figure 2008255078
Figure 2008255078

表9より、肌荒れ、肌のキメ、肌の透明感について、ガガイモ科カモメヅル属植物抽出物を含有しない比較例1、2使用群においては、半数以上のパネラーに改善が認められなかったが、ガガイモ科カモメヅル属植物抽出物を配合した実施例使用群おいては、70%以上のパネラーに明確な改善が認められた。このことから、ガガイモ科カモメヅル属植物抽出物は、肌荒れ、肌のキメ、肌の透明感において皮膚症状の改善に優れた効果を有することがわかった。   From Table 9, in the use groups of Comparative Examples 1 and 2 that do not contain the extract of the genus Camellia belonging to the genus Camellia family, no improvement was observed in more than half of the panelists regarding rough skin, skin texture, and skin transparency. In the example use group in which the plant gull genus plant extract was blended, a clear improvement was observed in 70% or more of the panelists. From this, it was found that the extract of the genus Camellia belonging to the genus Camellia family has an excellent effect in improving skin symptoms in rough skin, skin texture, and skin transparency.

以上のことから、ガガイモ科カモメヅル属植物抽出物は優れたトリートメント作用を有することが明らかとなった。   From the above, it has been clarified that the extract of the genus Camellia spp. Has an excellent treatment action.

Claims (8)

ガガイモ科(Asclepiadaceae)カモメヅル属(Cynanchum)植物より選ばれる1種または2種以上の植物またはその抽出物を有効成分とする保湿剤。 Asclepiadaceae (Asclepiadaceae) vincetoxicum (Cynanchum) 1 or more kinds of plants or humectant to the extract as an active ingredient selected from plants. ガガイモ科(Asclepiadaceae)カモメヅル属(Cynanchum)植物より選ばれる1種または2種以上の植物またはその抽出物を有効成分とする抗老化剤。 An anti-aging agent comprising, as an active ingredient, one or more plants selected from Asclepiadaceae plants and cynanchuum plants or extracts thereof. ガガイモ科(Asclepiadaceae)カモメヅル属(Cynanchum)植物より選ばれる1種または2種以上の植物またはその抽出物を有効成分とする美白剤。 Asclepiadaceae (Asclepiadaceae) vincetoxicum (Cynanchum) whitening to one or more plants or active ingredient the extract is selected from plant. ガガイモ科(Asclepiadaceae)カモメヅル属(Cynanchum)植物より選ばれる1種または2種以上の植物またはその抽出物を有効成分とする抗酸化剤。 An antioxidant comprising one or more plants selected from Asclepiadaceae and Cynanchum plants or extracts thereof as an active ingredient. ガガイモ科(Asclepiadaceae)カモメヅル属(Cynanchum)植物より選ばれる1種または2種以上の植物またはその抽出物を有効成分とする痩身剤。 Asclepiadaceae (Asclepiadaceae) vincetoxicum (Cynanchum) 1 or more kinds of plants or slimming agent to the extract as an active ingredient selected from plants. ガガイモ科(Asclepiadaceae)カモメヅル属(Cynanchum)植物より選ばれる1種または2種以上の植物またはその抽出物を有効成分とするトリートメント剤。 Asclepiadaceae (Asclepiadaceae) vincetoxicum (Cynanchum) treatment agent to one or more plants or active ingredient the extract is selected from plant. ガガイモ科(Asclepiadaceae)カモメヅル属(Cynanchum)植物より選ばれる1種または2種以上の植物またはその抽出物を有効成分とするアルギナーゼ活性促進剤。 An arginase activity promoter comprising, as an active ingredient, one or more plants selected from Asclepiadaceae plants and cynanchuum plants or extracts thereof. ガガイモ科(Asclepiadaceae)カモメヅル属(Cynanchum)植物より選ばれる1種または2種以上の植物またはその抽出物を含有することを特徴とする皮膚外用剤。 A skin external preparation characterized by containing one or more plants selected from Asclepiadaceae plants and cynanchuum plants or extracts thereof.
JP2007101941A 2007-04-09 2007-04-09 Moisturizer, anti-aging agent, whitening agent, antioxidant, slimming agent, treatment agent, arginase activity promoter and external preparation for skin Active JP5117092B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2007101941A JP5117092B2 (en) 2007-04-09 2007-04-09 Moisturizer, anti-aging agent, whitening agent, antioxidant, slimming agent, treatment agent, arginase activity promoter and external preparation for skin
PCT/JP2007/073499 WO2008129720A1 (en) 2007-04-09 2007-12-05 Moisturizing agent, antiaging agent, whitening agent, antioxidant, slimming agent, treatment agent, alginase activity promoter and external agent for the skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007101941A JP5117092B2 (en) 2007-04-09 2007-04-09 Moisturizer, anti-aging agent, whitening agent, antioxidant, slimming agent, treatment agent, arginase activity promoter and external preparation for skin

Publications (2)

Publication Number Publication Date
JP2008255078A true JP2008255078A (en) 2008-10-23
JP5117092B2 JP5117092B2 (en) 2013-01-09

Family

ID=39875258

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007101941A Active JP5117092B2 (en) 2007-04-09 2007-04-09 Moisturizer, anti-aging agent, whitening agent, antioxidant, slimming agent, treatment agent, arginase activity promoter and external preparation for skin

Country Status (2)

Country Link
JP (1) JP5117092B2 (en)
WO (1) WO2008129720A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012033162A1 (en) * 2010-09-09 2012-03-15 花王株式会社 Method for controlling hair growth, method for selecting or evaluating hair growth control agent, and hair growth suppression agent
JP2012056885A (en) * 2010-09-09 2012-03-22 Kao Corp Hair growth inhibitor
JP2018520704A (en) * 2015-07-10 2018-08-02 ブライノン、インコーポレイテッドBrainon Inc. A composition for athletic performance and muscle enhancement comprising continuation and Koikema extract as active ingredients
CN112716860A (en) * 2021-02-07 2021-04-30 艾后生物科技(上海)有限公司 Rod-like mud film with high moisture retention and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000053557A (en) * 1998-08-11 2000-02-22 Ichimaru Pharcos Co Ltd Cosmetic composition containing moisture-retentive plant extract
KR20020029181A (en) * 2000-10-12 2002-04-18 성재갑 Cosmetic composition containing Liquidambar taiwaniana Hance extracts and Cynanchum atratum Bunge extracts
JP2006199611A (en) * 2005-01-19 2006-08-03 Kao Corp Cosmetic

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000053557A (en) * 1998-08-11 2000-02-22 Ichimaru Pharcos Co Ltd Cosmetic composition containing moisture-retentive plant extract
KR20020029181A (en) * 2000-10-12 2002-04-18 성재갑 Cosmetic composition containing Liquidambar taiwaniana Hance extracts and Cynanchum atratum Bunge extracts
JP2006199611A (en) * 2005-01-19 2006-08-03 Kao Corp Cosmetic

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN6012038300; Lee,Dae-Won et al: 'Effect of culture conditions on the biosynthesis of gagaminine, a potent antioxidant from the roots' Biological & Pharmaceutical Bulletin Vol.24,No.12, 2001, pp.1451-1453 *
JPN6012038302; Lee,Dong-Ung et al: 'Inhibitory effects of polyoxypregnane constituents from the roots of Cynanchum caudatum on the alde' Yakhak Hoeji Vol.44,No.3, 2000, pp.257-262 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012033162A1 (en) * 2010-09-09 2012-03-15 花王株式会社 Method for controlling hair growth, method for selecting or evaluating hair growth control agent, and hair growth suppression agent
JP2012056885A (en) * 2010-09-09 2012-03-22 Kao Corp Hair growth inhibitor
US9005898B2 (en) 2010-09-09 2015-04-14 Kao Corporation Method for controlling hair growth, method for selecting or evaluating hair growth control agent, and hair growth suppression agent
JP2018520704A (en) * 2015-07-10 2018-08-02 ブライノン、インコーポレイテッドBrainon Inc. A composition for athletic performance and muscle enhancement comprising continuation and Koikema extract as active ingredients
US10660927B2 (en) 2015-07-10 2020-05-26 Brainon Inc. Composition, containing extracts of Dipsacus asperoides and Cynanchum wilfordii as active ingredients, for promoting motor ability and muscles
CN112716860A (en) * 2021-02-07 2021-04-30 艾后生物科技(上海)有限公司 Rod-like mud film with high moisture retention and preparation method thereof

Also Published As

Publication number Publication date
WO2008129720A1 (en) 2008-10-30
JP5117092B2 (en) 2013-01-09

Similar Documents

Publication Publication Date Title
JP4425163B2 (en) Anti-aging cosmetics
JP5117092B2 (en) Moisturizer, anti-aging agent, whitening agent, antioxidant, slimming agent, treatment agent, arginase activity promoter and external preparation for skin
JP2008303147A (en) External preparation for skin
JP5014343B2 (en) Nemagaridake-containing composition, moisturizer, cell activator, whitening agent and antioxidant
JP2009143849A (en) Anti-aging agent, skin whitening agent, antioxidant, anti-inflammatory agent, and humectant
JP2008201694A (en) External preparation for skin
JP5247548B2 (en) Moisturizer, anti-aging agent, neutral fat accumulation inhibitor, whitening agent, anti-inflammatory agent, topical skin preparation, oral preparation
JP2011046646A (en) Antioxidant and skin external preparation
JP5383001B2 (en) Skin preparations, moisturizers, anti-aging agents, antioxidants, anti-inflammatory agents, whitening agents, and slimming agents
JP2007277100A (en) Humectant, cell activator, dermal fibroblast activator, epidermal cell activator, collagen production accelerator, antioxidant, anti-aging agent, beautifully whitening agent or melanin production inhibitor
JP4748962B2 (en) Moisturizer, cell activator, whitening agent, and antioxidant
JP3754025B2 (en) Cell activator, antioxidant, and skin external preparation
JP5313003B2 (en) Moisturizer
JP4480366B2 (en) Cell activator, whitening agent, hyaluronic acid production promoter, collagen production promoter, antioxidant, and skin external preparation
JP2010241734A (en) Skin external preparation
JP4931452B2 (en) Moisturizer, cell activator, whitening agent, and antioxidant
JP5116428B2 (en) Moisturizer and external preparation for skin
JP4050727B2 (en) Moisturizer, cell activator, whitening agent, antioxidant, and skin external preparation
JP5202180B2 (en) Moisturizer, immunostimulant, anti-aging agent, whitening agent, antioxidant, slimming agent, external preparation for skin and functional oral composition
JP4291647B2 (en) Cell activator, whitening agent, collagen production promoter, antioxidant, and skin external preparation
JP5383384B2 (en) Anti-aging agent, antioxidant, whitening agent, and immunostimulant
JP4018605B2 (en) Cell activating agent, whitening agent, antioxidant, and skin external preparation
JP5610806B2 (en) Antioxidants and external preparations for skin
JP5265489B2 (en) Moisturizer, anti-aging agent, antioxidant, whitening agent, anti-inflammatory agent, immunostimulant, topical skin preparation, oral preparation
JP4050674B2 (en) Cell activator, whitening agent, hyaluronic acid production promoter, elastin production promoter, antioxidant, and external preparation for skin

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100308

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120724

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120906

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20120906

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20121016

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20121017

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 5117092

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20151026

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250